Skip to content

Comparison of Surgical Versus Medical Termination of Pregnancy Between 13-20 Weeks of Gestation in Ethiopia

Comparison of Surgical Versus Medical Termination of Pregnancy Between 13-20 Weeks of Gestation in Ethiopia: A Quasi-experimental Study.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04602052
Enrollment
279
Registered
2020-10-26
Start date
2018-11-01
Completion date
2019-10-31
Last updated
2020-10-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Termination of Pregnancy

Keywords

Dilation and evacuation, Second Trimester, Medical abortion, Ethiopia

Brief summary

The purpose of the study is to determine the safety and effectiveness of dilation and evacuation for surgical abortion as compared to medical abortion

Detailed description

All patients with a gestational age between 13-20 weeks are fully counseled on the risks and benefits and given the option of medical or surgical abortion. Those who choose medical abortion receive mifepristone 200 mg on day 1 and are appointed to return to SPHMMC 24-48 hours later for admission and misoprostol administration. Those who chose surgical abortion are given mifepristone 200 mg with or without laminaria and appointed to return the next day for surgical abortion.

Interventions

PROCEDUREDilation and evacuation

Abortion is termination of pregannacy by evaccuating the uterus using either medical or surgical technique

Sponsors

St. Paul's Hospital Millennium Medical College, Ethiopia
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Gestational age between 13 - 20 weeks confirmed with ultrasound, * Age at or more than18 years, * Having a working phone and willingness to be contacted for a follow-up questionnaire 2 weeks after the procedure.

Exclusion criteria

* Inability to give consent * complicated abortion (missed abortion, septic abortion)

Design outcomes

Primary

MeasureTime frameDescription
Composite complication rateDuring the abortion procedure and within 2 weeks post procedurePresence of one of the following complications: bleeding requiring observation, genital tract lacerations requiring repair, need for additional intervention to complete the abortion procedure, and one or more symptoms of pelvic infection

Secondary

MeasureTime frameDescription
Other serious maternal complicationsDuring the abortion procedure and within 2 weeks post procedureContinued bleeding for more than two weeks, additional major surgery (laparotomy), and death.

Countries

Ethiopia

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026